Mogamulizumab-induced bone granuloma

Joint Bone Spine. 2024 Sep 25;92(1):105782. doi: 10.1016/j.jbspin.2024.105782. Online ahead of print.
No abstract available

Keywords: Adverse event; Bone granuloma; CCR4; Mogamulizumab; Mogamulizumab-associated rash; Mycosis fungoides; PTCL; Sezary syndrome.

Publication types

  • Letter